Neuroone Medical Technologies (NMTC) Asset Utilization Ratio (2011 - 2026)

Neuroone Medical Technologies has disclosed Asset Utilization Ratio across 11 years of filings, most recently posting 1.14 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 8.26% year-over-year to 1.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.14 (up 8.26% YoY) and the FY2025 annual result came in at 1.13, up 119.63% from the prior year.
• Asset Utilization Ratio rose to 1.14 in Q1 2026, from 0.9 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 1.14 in Q1 2026 and bottomed at 0.01 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.66 (2024), against an average of 0.52.
• Year-over-year, Asset Utilization Ratio slumped 30.1% in 2022 and surged 1908.19% in 2023.
• Neuroone Medical Technologies' Asset Utilization Ratio stood at 0.02 in 2022, then soared by 1704.59% to 0.4 in 2023, then soared by 139.58% to 0.97 in 2024, then slipped by 7.11% to 0.9 in 2025, then grew by 26.47% to 1.14 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 1.14, 0.9, and 0.84 for Q1 2026, Q4 2025, and Q3 2025 respectively.